PRKG1 hinders myogenic differentiation and predicts response to AKT inhibitor ipatasertib in Rhabdomyosarcoma

Journal:

Nature Communications

Published:

2025-11-06

DOI:

10.1038/s41467-025-64783-3

Affiliations:

5

Authors:

24

Go to article

Institutions	Authors	Share
Sant Joan de Déu Research Institute (IRSJD), Spain	9.500000	0.40
Institute for Research in Biomedicine (IRB Barcelona), BIST, Spain	5.500000	0.23
Hospital del Mar Medical Research Institute (IMIM), Spain	3.500000	0.15
Nostrum Biodiscovery SL, Spain	3.000000	0.13
SJD Barcelona Children's Hospital​ for Maternal and Child Health, BMA, Spain	2.500000	0.10

Interested in Oncology and Carcinogenesis?